Literature DB >> 12453073

The importance of educational and psychological factors in Parkinson's disease quality of life.

E Cubo1, A Rojo, S Ramos, S Quintana, M Gonzalez, K Kompoliti, M Aguilar.   

Abstract

OBJECTIVE: To define the factors correlated with quality of life (QoL) in patients with idiopathic Parkinson's disease (PD).
BACKGROUND: PD has a substantial impact on QoL. Although several clinical factors have been associated with QoL in PD, the influence of patient's education still remains controversial.
METHODOLOGY: A consecutive series of patients with PD were examined using the unified Parkinson's Disease Rating Scale (UPDRS part I, II, III), Schwab and England (SE), and Hoehn and Yahr stage (H&Y). QoL was rated with the PDQ-39, cognition with the Mini-Mental State examination (MMSE), and the presence of depressive symptoms with the geriatric depression scale (GDS). Patient's characteristics, estimated cumulative levodopa dose (CLD), UPDRS, H&Y, MMSE and GDS were correlated with the PDQ-39 using univariate and multiple regression analysis.
RESULTS: A total of one hundred 58 patients (68 men, 90 women) with a mean age of 65.6 +/- 9.3 years, PD duration of 8.1 +/- 10.6 years, and education of 6.6 +/- 3.9 years were included. The mean PDQ-39 was 48.8 +/- 27.8, mean MMSE was 25.7 +/- 4, and mean GDS was 11.7 +/- 6.8. Using stepwise multiple regression analysis, the most important predictive factors were depression, UPDRS part I, UPDRS part II, and educational background, which accounted for a 61% of the variability of the PDQ-39 scores.
CONCLUSIONS: In our PD sample, educational, behavioural, and psychological factors influenced life satisfaction more than physical ones.

Entities:  

Mesh:

Year:  2002        PMID: 12453073     DOI: 10.1046/j.1468-1331.2002.00484.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  20 in total

1.  Mood and motor trajectories in Parkinson's disease: multivariate latent growth curve modeling.

Authors:  Laura B Zahodne; Michael Marsiske; Michael S Okun; Ramon L Rodriguez; Irene Malaty; Dawn Bowers
Journal:  Neuropsychology       Date:  2011-12-05       Impact factor: 3.295

2.  Depression and intelligence in patients with Parkinson's disease and deep-brain stimulation.

Authors:  Courtney R Schadt; Katie L Cox; Michael G Tramontana; Daniel W Byrne; Thomas L Davis; John Y Fang; Peter E Konrad; Bhavna Padaliya; Robert W Mutter; Chandler E Gill; Caralee R Richardson; P David Charles
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

3.  Personality and reported quality of life in Parkinson's disease.

Authors:  Gregory M Pontone; Zoltan Mari; Kate Perepezko; Howard D Weiss; Susan S Bassett
Journal:  Int J Geriatr Psychiatry       Date:  2016-04-05       Impact factor: 3.485

Review 4.  A review of the health-related quality of life and economic impact of Parkinson's disease.

Authors:  Clare H Dowding; Claire L Shenton; Sam S Salek
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

5.  A comprehensive model of health-related quality of life in Parkinson's disease.

Authors:  M Visser; S M van Rooden; D Verbaan; J Marinus; A M Stiggelbout; J J van Hilten
Journal:  J Neurol       Date:  2008-09-24       Impact factor: 4.849

6.  Behind the mask : a study on the clinical course, psychopathology and impact on quality of life in idiopathic Parkinson's disease.

Authors:  Neena S Sawant; S R Parkar; Heena R Merchant; Avinash A De Sousa; S H Ravat
Journal:  Indian J Psychiatry       Date:  2004-10       Impact factor: 1.759

7.  Predictors of health status in nondepressed and nondemented individuals with Parkinson's disease.

Authors:  Dawn M Schiehser; S Duke Han; Stephanie Lessig; David D Song; Vanessa Zizak; J Vincent Filoteo
Journal:  Arch Clin Neuropsychol       Date:  2009-09-18       Impact factor: 2.813

8.  The Key Determinants to Quality of Life in Parkinson's Disease Patients: Results from the Parkinson's Disease Biomarker Program (PDBP).

Authors:  Lu He; Eun-Young Lee; Nicholas W Sterling; Lan Kong; Mechelle M Lewis; Guangwei Du; Paul J Eslinger; Xuemei Huang
Journal:  J Parkinsons Dis       Date:  2016-05-31       Impact factor: 5.568

9.  Pharmacologic treatment of anxiety disorders in Parkinson disease.

Authors:  Gregory M Pontone; James R Williams; Karen E Anderson; Gary Chase; Susanne R Goldstein; Stephen Grill; Elaina S Hirsch; Susan Lehmann; John T Little; Russell L Margolis; Justin Palanci; Peter V Rabins; Howard D Weiss; Laura Marsh
Journal:  Am J Geriatr Psychiatry       Date:  2013-03-29       Impact factor: 4.105

10.  Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors.

Authors:  Staci D Arnold; Leslie M Forman; Bart D Brigidi; Karen E Carter; Holly A Schweitzer; Heather E Quinn; A Bebe Guill; James E Herndon; Renee H Raynor
Journal:  Neuro Oncol       Date:  2008-02-26       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.